Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.17 USD | -2.28% | +15.08% | +17.60% |
Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
Apr. 24 | Needham Adjusts Price Target on Day One Biopharmaceuticals to $33 From $30, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.60% | 1.54B | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- DAWN Stock
- News Day One Biopharmaceuticals, Inc.
- Needham Initiates Coverage on Day One Biopharmaceuticals With Buy Rating, $40 Price Target